CHRONIC IMMUNE THROMBOCYTOPENIA
Clinical trials for CHRONIC IMMUNE THROMBOCYTOPENIA explained in plain language.
Never miss a new study
Get alerted when new CHRONIC IMMUNE THROMBOCYTOPENIA trials appear
Sign up with your email to follow new studies for CHRONIC IMMUNE THROMBOCYTOPENIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for low platelets: avatrombopag tested in japanese ITP patients
Disease control CompletedThis study tested a drug called avatrombopag in 19 Japanese adults with chronic immune thrombocytopenia (ITP), a condition where the immune system destroys platelets, raising bleeding risk. The goal was to see if the drug could safely increase platelet counts over 26 weeks. Parti…
Matched conditions: CHRONIC IMMUNE THROMBOCYTOPENIA
Phase: PHASE3 • Sponsor: Sobi, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
ITP study reveals hidden toll on brain and body
Knowledge-focused CompletedThis study looked at how chronic immune thrombocytopenia (ITP) affects thinking skills and fatigue in adults. Researchers measured brain function and inflammation using blood tests and questionnaires in 97 patients. The goal was to better understand these connections, not to test…
Matched conditions: CHRONIC IMMUNE THROMBOCYTOPENIA
Sponsor: Sanofi • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:14 UTC